跳至主要内容
临床试验/TCTR20190830003
TCTR20190830003招募中未知

Efficacy of split-dosing versus nonsplit-dosing of ergocalciferol on serum 25-hydroxyvitamin D in chronic kidney disease patients

Phramongkutklao Hospital0 个研究点目标入组 76 人开始时间: 2019年8月30日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Female

入选标准

  • 1. Patients with chronic kidney disease stage 3-5 before dialysis
  • 2. Patients aged 18 - 80 years old
  • 3. Level 25 (OH) D in the blood, less than 30 ng / mL

排除标准

  • 1 patients who have been diagnosed as primary or tertiary hyperparathyroidism
  • 2 Patients who have previously received vitamin D ergocalciferol
  • 3 Patients receiving active form of vitamin D
  • 4 Blood calcium levels greater than 10.5 mg / dL
  • 5 Blood phosphate levels greater than 5.5 mg / dL
  • 7 Chronic diseases expected to die within 6 months

研究者

相似试验